Morten Ruhwald

Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases.

Tuberculosis burden in an urban population: a cross sectional tuberculosis survey from Guinea Bissau.

6-year follow-up of 522 HIV-positive individuals screened for Mycobacterium tuberculosis infection in Denmark.

Development of a one-step probe based molecular assay for rapid immunodiagnosis of infection with M. tuberculosis using dried blood spots.

A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human.

Human B cells produce chemokine CXCL10 in the presence of Mycobacterium tuberculosis specific T cells.

IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection.

Towards tuberculosis elimination: an action framework for low-incidence countries.

Sensitivity of C-Tb: a novel RD-1-specific skin test for the diagnosis of tuberculosis infection.

Performance of Interferon-Gamma and IP-10 Release Assays for Diagnosing Latent Tuberculosis Infections in Patients with Concurrent Malaria in Tanzania.

Design of tuberculosis vaccine trials under financial constraints.

Thermostability of IFN-γ and IP-10 release assays for latent infection with Mycobacterium tuberculosis: A TBnet study.

TB biomarkers, TB correlates and human challenge models: New tools for improving assessment of new TB vaccines.

TB vaccines in clinical development.

New tests for detection of Mycobacterium tuberculosis infection: sufficient to meet the WHO 2035 targets?

H1:IC31 vaccination is safe and induces long-lived TNF-αIL-2CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial.

Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial.

Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6.

Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis.

Antigen Availability Shapes T Cell Differentiation and Function during Tuberculosis.

Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of Mycobacterium tuberculosis Infection.

Use of IFN-γ and IP-10 detection in the diagnosis of latent tuberculosis infection in patients with inflammatory rheumatic diseases.

Interplay of DDP4 and IP-10 as a Potential Mechanism for Cell Recruitment to Tuberculosis Lesions.

Determination of anti-HCV and quantification of HCV-RNA and IP-10 from dried blood spots sent by regular mail.

Acute phase proteins and IP-10 as triage tests for the diagnosis of tuberculosis: a systematic review and meta-analysis.

Dose Optimization of H56:IC31 Vaccine for TB Endemic Populations: A Double-Blind, Placebo-Controlled, Dose-Selection Trial.